As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder. Â
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder. Â
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder. Â
Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, provides a quick overview of some of the most widely accessible screening tools for pediatric and adult attention-deficit/hyperactivity disorder. Â
Vladimir Maletic, MD, MS, discusses living with, treating, and managing pediatric ADHD over the summer months. Dr Maletic gives practical advice for clinicians treating these patients and knowledge to share with caretakers.
Vladimir Maletic, MD, MS, discusses living with, treating, and managing pediatric ADHD over the summer months. Dr Maletic gives practical advice for clinicians treating these patients and knowledge to share with caretakers.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet Singh, MD, MS, discusses introducing stimulant therapy for ADHD management, differentiating pediatric ADHD from mood disorders, and gender or ethnic bias during diagnosis.
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD.Â
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD.Â
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Dr Maletic is interviewed about the pandemic’s impact on different age groups of children with pediatric ADHD and how parents and schools can support children during the back-to-school transition.
Dr Maletic is interviewed about the pandemic’s impact on different age groups of children with pediatric ADHD and how parents and schools can support children during the back-to-school transition.
Increased screen time, diet changes, social impacts affects and other COVID-19 pandemic outcomes impact children with pediatric ADHD at varying levels depending on disorder severity, says Vladimir Maletic, MD, MS.
Increased screen time, diet changes, social impacts affects and other COVID-19 pandemic outcomes impact children with pediatric ADHD at varying levels depending on disorder severity, says Vladimir Maletic, MD, MS.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
Desiree Matthews, PMHNP-BC, CEO, Different MHP, highlights how providers can integrate medication management into their virtual practices—especially for patients needing long-acting injectable (LAI) antipsychotics.
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
Episodes of fever experienced during the first 4 years of life are associated with a higher rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis during childhood and demonstrates a dose-response relationship.
Episodes of fever experienced during the first 4 years of life are associated with a higher rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis during childhood and demonstrates a dose-response relationship.
Exposure to lead during childhood, but not prenatal exposure, may increase the chances of subsequent attention-deficit/hyperactivity disorder (ADHD) symptoms and diagnosis.
Exposure to lead during childhood, but not prenatal exposure, may increase the chances of subsequent attention-deficit/hyperactivity disorder (ADHD) symptoms and diagnosis.
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Of the 3.3% of youth in a recent study that had exclusively undergone non-stimulant therapy for ADHD, what percentage reported prescription stimulant misuse in the past year?
Of the 3.3% of youth in a recent study that had exclusively undergone non-stimulant therapy for ADHD, what percentage reported prescription stimulant misuse in the past year?
T or F: According to the DSM-5-TR, ADHD is not diagnosed if the symptoms of inattention and hyperactivity occur exclusively during the course of a psychotic disorder.
T or F: According to the DSM-5-TR, ADHD is not diagnosed if the symptoms of inattention and hyperactivity occur exclusively during the course of a psychotic disorder.
Pop Quiz: According to a recent study published in JAMA Network Open, what percent of children with parent-reported DSM-5 criteria for ADHD were currently receiving ADHD medications?
Pop Quiz: According to a recent study published in JAMA Network Open, what percent of children with parent-reported DSM-5 criteria for ADHD were currently receiving ADHD medications?
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
How to Use
Patients simply check 1 of the 5 boxes in response to each of the 6 questions.Â
Click here for website for ASRS-VI.I
How to Score
If 4 or more marks appear in the darkly shaded boxes within the questionnaire, the...
How to Use
Patients simply check 1 of the 5 boxes in response to each of the 6 questions.Â
Click here for website for ASRS-VI.I
How to Score
If 4 or more marks appear in the darkly shaded boxes within the questionnaire, the...
Click here for ADHD Rating Scales Website
How to Use:
ADHD Rating Scales ( www.adhdratingscales.com ) is an online resource dedicated to increasing the efficient use of ADHD rating scales in everyday clinical...
Click here for ADHD Rating Scales Website
How to Use:
ADHD Rating Scales ( www.adhdratingscales.com ) is an online resource dedicated to increasing the efficient use of ADHD rating scales in everyday clinical...
How to Use
The ADHD Rating Scale-IV obtains parent ratings regarding the frequency of each ADHD symptom based on DSM-IV criteria. Parents are asked to determine symptomatic frequency that describes the child’s home behavior over the...
How to Use
The ADHD Rating Scale-IV obtains parent ratings regarding the frequency of each ADHD symptom based on DSM-IV criteria. Parents are asked to determine symptomatic frequency that describes the child’s home behavior over the...
Click here for Medication Adherence Rating Scale (MARS) - page 7
The total score ranges from 0-10 with a higher score indicating better adherence
Strengths
Self-report...
Click here for Medication Adherence Rating Scale (MARS) - page 7
The total score ranges from 0-10 with a higher score indicating better adherence
Strengths
Self-report...
Click here for website for SDS
How to Use
The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
How to Score
Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS
How to Use
The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
How to Score
Total score 0-30 (0 unimpaired, 30 highly...
How to Use
The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale.
The BPRS is used as part of a clinical interview in which the clinician makes...
How to Use
The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale.
The BPRS is used as part of a clinical interview in which the clinician makes...
How to Use
The MINI is a widely used psychiatric structured diagnostic interview instrument.
To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.
The MINI...
How to Use
The MINI is a widely used psychiatric structured diagnostic interview instrument.
To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.
The MINI...
How to Use
The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.
Click here for the website for the MINI Screen
How to...
How to Use
The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.
Click here for the website for the MINI Screen
How to...
How to Use
The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use
The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use
Five items rated on 6-point Likert scale
Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use
The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.
The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use
The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.
The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
Click here for a PDF of the HAM-A
Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
Click here for a PDF of the HAM-A
Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
In 3 pediatric cohorts in Spain, children with sleep problems at ages 8 and 9 were at increased risk of attention-deficit/hyperactivity disorder (ADHD) symptoms in preadolescence. Researchers published their findings in the European Journal...
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
Acetaminophen use during pregnancy does not increase children’s risk of neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and intellectual disability.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
A larger span of spoken words was genetically linked with an increased risk of attention-deficit/hyperactivity disorder (ADHD) and more ADHD symptoms in infants, but by toddlerhood the genetic relationship was reversed.
Episodes of fever experienced during the first 4 years of life are associated with a higher rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis during childhood and demonstrates a dose-response relationship.
Episodes of fever experienced during the first 4 years of life are associated with a higher rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis during childhood and demonstrates a dose-response relationship.
Exposure to lead during childhood, but not prenatal exposure, may increase the chances of subsequent attention-deficit/hyperactivity disorder (ADHD) symptoms and diagnosis.
Exposure to lead during childhood, but not prenatal exposure, may increase the chances of subsequent attention-deficit/hyperactivity disorder (ADHD) symptoms and diagnosis.
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.